Despite its therapeutic potential, YB-1 has historically been considered "undruggable" due to its lack of a deep enzymatic active site and its intrinsically disordered structure. YBox-01 emerges as a breakthrough solution to this problem. Originally developed as a specific small-molecule inhibitor (or antisense oligonucleotide, depending on the specific proprietary platform), YBox-01 disrupts the interaction between YB-1 and its target DNA/RNA sequences, effectively silencing its pro-survival signaling.
It is powered by a Rockchip RK322x processor with 1GB of RAM and roughly 4.8GB of usable storage. Update Status Official Firmware: ybox-01 update